Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

FHD-609

😃Good
Catalog No. T75135Cas No. 2676211-64-4
Alias FHD609, FHD 609

FHD-609 is an effective BRD9 inhibitor and PROTAC degrader, targeting the non-classical BAF (ncBAF) subunit BRD9, thereby depleting the SS18-SSX fusion protein, and can be used for the study of synovial sarcoma (SS).

FHD-609

FHD-609

😃Good
Purity: 99.96%
Catalog No. T75135Alias FHD609, FHD 609Cas No. 2676211-64-4
FHD-609 is an effective BRD9 inhibitor and PROTAC degrader, targeting the non-classical BAF (ncBAF) subunit BRD9, thereby depleting the SS18-SSX fusion protein, and can be used for the study of synovial sarcoma (SS).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$66-In Stock
5 mg$158-In Stock
10 mg$248-In Stock
25 mg$397-In Stock
50 mg$569-In Stock
100 mg$786-In Stock
1 mL x 10 mM (in DMSO)$229-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.96%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
FHD-609 is an effective BRD9 inhibitor and PROTAC degrader, targeting the non-classical BAF (ncBAF) subunit BRD9, thereby depleting the SS18-SSX fusion protein, and can be used for the study of synovial sarcoma (SS).
In vivo
In the SYO-1 xenograft mouse model, FHD-609 (1 mg/kg, intravenous injection, twice weekly for 28 days) maintained BRD9 degradation levels for 28 days and exhibited antitumor activity [3].
SynonymsFHD609, FHD 609
Chemical Properties
Molecular Weight829
FormulaC47H56N8O6
Cas No.2676211-64-4
SmilesC(N1CCC2(CN(C2)C=3C=C4C(=CC3)CN(C4=O)[C@@H]5C(=O)NC(=O)CC5)CC1)C6CCN(CC7=C(OC)C=C(C=C7OC)C=8C=9C(=CN=C(C9)N%10CCC%10)C(=O)N(C)C8)CC6
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (96.5 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2063 mL6.0314 mL12.0627 mL60.3136 mL
5 mM0.2413 mL1.2063 mL2.4125 mL12.0627 mL
10 mM0.1206 mL0.6031 mL1.2063 mL6.0314 mL
20 mM0.0603 mL0.3016 mL0.6031 mL3.0157 mL
50 mM0.0241 mL0.1206 mL0.2413 mL1.2063 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy FHD-609 | purchase FHD-609 | FHD-609 cost | order FHD-609 | FHD-609 chemical structure | FHD-609 in vivo | FHD-609 formula | FHD-609 molecular weight